期刊文献+

代谢综合征与血栓前状态. 被引量:9

Metabolic syndrome and prothrombotic state
原文传递
导出
摘要 代谢综合征可通过胰岛素抵抗或中心性肥胖形成血栓前状态。胰岛素抵抗或中心性肥胖可导致纤溶酶原激活物抑制剂-1(PAI-1)、纤维蛋白原、组织因子和凝血因子Ⅶ升高,一氧化氮(N0)生物活性减弱、血管内皮损伤,抑制血小板聚集的能力减弱,使血小板活化。因此,胰岛素抵抗或中心性肥胖通过影响凝血系统、纤溶系统、血小板和血管内皮等促进代谢综合征血栓前状态的形成。 Metabolic syndrome is prone to form prothrombotic state through insulin resistance or central obesity. Insulin resistance or central obesity can increase the levels of plasminogen activator inhibitor-1 (PAI-1) ,fibrinogen,tissue factor and coagulation factor Ⅶ. Insulin resistance can reduce the activity of nitric oxide (NO), which protects vascular endothehum. Insulin resistance combined with central obesity can lower the function of insulin,which suppresses platelet aggregation. In conclusion,insulin resistance or central obesity can promote the development of prothrombotic state by increasing the level of coagulation factor,inhibiting the fibrinolytic pathway, accelerating platelet activation and damaging vascular endothelial function.
作者 朱筱琦 钟远
出处 《国际内分泌代谢杂志》 2007年第6期412-414,共3页 International Journal of Endocrinology and Metabolism
关键词 代谢综合征 胰岛素抵抗 血栓前状态 Metabolic syndrome Insulin resistance Prothrombotic state
  • 相关文献

参考文献18

  • 1International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, IDF, Brussels, 2005. Available at http ://www. idf. org/webdate/docs/IDF _ metasyndrome _ definition. pdf.
  • 2Appl SJ, Harrell JS, Davenport ML. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. J Am Acad Nurse Pract,2005,17:535-541.
  • 3Solano MP,Perry AC, Wang X, et al. Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women. Int J Obes Relat Metab Disord ,2003,27 : 82-87.
  • 4Kahn SE, Zinman B, Haffner SM, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes,2006,55:2357-2364.
  • 5Kopp CW,Kopp HP,Steiner S,et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res,2003 ,11:950-956.
  • 6Yudkin JS, Juhan-Vague I, Hawe E, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism, 2004,53:852-857.
  • 7Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation,2005,112:32-38.
  • 8Barbato JE, Zuckerbraun BS, Overhaus M, et al. Nitric oxide vascular inflammation and intimal hyperplasia in insulin resistance and metabolic syndrome. Am J physiol Heart Circ Physiol, 2005, 289: H228-H236.
  • 9Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (P) H oxidase and endothelial nitric oxide synthase. Circulation, 2002,105 : 1656-1662.
  • 10Arteaga RB, Chirinos JA, Soriano AO, et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol,2006 ,98 :70-74.

同被引文献101

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部